BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33148671)

  • 1. Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers.
    Tsang ES; Grisdale CJ; Pleasance E; Topham JT; Mungall K; Reisle C; Choo C; Carreira M; Bowlby R; Karasinska JM; MacMillan D; Williamson LM; Chuah E; Moore RA; Mungall AJ; Zhao Y; Tessier-Cloutier B; Ng T; Sun S; Lim HJ; Schaeffer DF; Renouf DJ; Yip S; Laskin J; Marra MA; Jones SJM; Loree JM
    Clin Cancer Res; 2021 Jan; 27(2):522-531. PubMed ID: 33148671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved detection of clinically relevant fusion transcripts in cancer by machine learning classification.
    Hafstað V; Häkkinen J; Larsson M; Staaf J; Vallon-Christersson J; Persson H
    BMC Genomics; 2023 Dec; 24(1):783. PubMed ID: 38110872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS.
    van Belzen IAEM; Cai C; van Tuil M; Badloe S; Strengman E; Janse A; Verwiel ETP; van der Leest DFM; Kester L; Molenaar JJ; Meijerink J; Drost J; Peng WC; Kerstens HHD; Tops BBJ; Holstege FCP; Kemmeren P; Hehir-Kwa JY
    BMC Cancer; 2023 Jul; 23(1):618. PubMed ID: 37400763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
    Gaonkar KS; Marini F; Rathi KS; Jain P; Zhu Y; Chimicles NA; Brown MA; Naqvi AS; Zhang B; Storm PB; Maris JM; Raman P; Resnick AC; Strauch K; Taroni JN; Rokita JL
    BMC Bioinformatics; 2020 Dec; 21(1):577. PubMed ID: 33317447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of clinically relevant fusions in pediatric cancer.
    LaHaye S; Fitch JR; Voytovich KJ; Herman AC; Kelly BJ; Lammi GE; Arbesfeld JA; Wijeratne S; Franklin SJ; Schieffer KM; Bir N; McGrath SD; Miller AR; Wetzel A; Miller KE; Bedrosian TA; Leraas K; Varga EA; Lee K; Gupta A; Setty B; Boué DR; Leonard JR; Finlay JL; Abdelbaki MS; Osorio DS; Koo SC; Koboldt DC; Wagner AH; Eisfeld AK; Mrózek K; Magrini V; Cottrell CE; Mardis ER; Wilson RK; White P
    BMC Genomics; 2021 Dec; 22(1):872. PubMed ID: 34863095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Landscape of gene fusions in epithelial cancers: seq and ye shall find.
    Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
    Genome Med; 2015 Dec; 7():129. PubMed ID: 26684754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer.
    Kloosterman WP; Coebergh van den Braak RRJ; Pieterse M; van Roosmalen MJ; Sieuwerts AM; Stangl C; Brunekreef R; Lalmahomed ZS; Ooft S; van Galen A; Smid M; Lefebvre A; Zwartkruis F; Martens JWM; Foekens JA; Biermann K; Koudijs MJ; Ijzermans JNM; Voest EE
    Cancer Res; 2017 Jul; 77(14):3814-3822. PubMed ID: 28512242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-seq Fusion Detection in Clinical Oncology.
    Hedges DJ
    Adv Exp Med Biol; 2022; 1361():163-175. PubMed ID: 35230688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing.
    Cieslik M; Chugh R; Wu YM; Wu M; Brennan C; Lonigro R; Su F; Wang R; Siddiqui J; Mehra R; Cao X; Lucas D; Chinnaiyan AM; Robinson D
    Genome Res; 2015 Sep; 25(9):1372-81. PubMed ID: 26253700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast and sensitive validation of fusion transcripts in whole-genome sequencing data.
    Hafstað V; Häkkinen J; Persson H
    BMC Bioinformatics; 2023 Sep; 24(1):359. PubMed ID: 37741966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays.
    Kirchner M; Glade J; Lehmann U; Merkelbach-Bruse S; Hummel M; Lehmann A; Trautmann M; Kumbrink J; Jung A; Dietmaier W; Endris V; Kazdal D; Ploeger C; Evert M; Horst D; Kreipe H; Kirchner T; Wardelmann E; Büttner R; Weichert W; Dietel M; Schirmacher P; Stenzinger A; Pfarr N
    Genes Chromosomes Cancer; 2020 Aug; 59(8):445-453. PubMed ID: 32319699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SFyNCS detects oncogenic fusions involving non-coding sequences in cancer.
    Zhong X; Luan J; Yu A; Lee-Hassett A; Miao Y; Yang L
    Nucleic Acids Res; 2023 Oct; 51(18):e96. PubMed ID: 37638762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Fusion Discovery with INTEGRATE.
    Zhang J; Maher CA
    Methods Mol Biol; 2020; 2079():41-68. PubMed ID: 31728961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data.
    Shah N; Lankerovich M; Lee H; Yoon JG; Schroeder B; Foltz G
    BMC Genomics; 2013 Nov; 14(1):818. PubMed ID: 24261984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-Seq for the detection of gene fusions in solid tumors: development and validation of the JAX FusionSeq™ 2.0 assay.
    Bergeron D; Chandok H; Nie Q; Prego M; Soucy M; Kelly K; Ananda G; Hesse A; Reddi HV
    J Mol Med (Berl); 2022 Feb; 100(2):323-335. PubMed ID: 35013752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target.
    Yakirevich E; Resnick MB; Mangray S; Wheeler M; Jackson CL; Lombardo KA; Lee J; Kim KM; Gill AJ; Wang K; Gowen K; Sun J; Miller VA; Stephens PJ; Ali SM; Ross JS; Safran H
    Clin Cancer Res; 2016 Aug; 22(15):3831-40. PubMed ID: 26933125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets.
    Arbajian E; Puls F; Antonescu CR; Amary F; Sciot R; Debiec-Rychter M; Sumathi VP; Järås M; Magnusson L; Nilsson J; Hofvander J; Mertens F
    Clin Cancer Res; 2017 Dec; 23(23):7426-7434. PubMed ID: 28939748
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent
    Khuong-Quang DA; Brown LM; Wong M; Mayoh C; Sexton-Oates A; Kumar A; Pinese M; Nagabushan S; Lau L; Ludlow LE; Gifford AJ; Rodriguez M; Desai J; Fox SB; Haber M; Ziegler DS; Hansford JR; Marshall GM; Cowley MJ; Ekert PG
    Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33144287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INTEGRATE: gene fusion discovery using whole genome and transcriptome data.
    Zhang J; White NM; Schmidt HK; Fulton RS; Tomlinson C; Warren WC; Wilson RK; Maher CA
    Genome Res; 2016 Jan; 26(1):108-18. PubMed ID: 26556708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy.
    Hsiao SJ; Zehir A; Sireci AN; Aisner DL
    J Mol Diagn; 2019 Jul; 21(4):553-571. PubMed ID: 31075511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.